AMPX stock jumped 19.35% intraday to $13.88 after Amprius Technologies, Inc. (AMPX) reported stronger-than-expected Q4/FY2025 results and issued FY2026 guidance that beat estimates. Trading on the NYSE in the United States, volume spiked to 19,486,446 shares versus an average of 7,328,413, driving a day high of $15.05. Today’s move follows the company’s earnings release and management commentary that pushed investor interest in Amprius’s silicon-anode battery growth story, while spotlighting execution risk as the firm scales production and revenue in USD.

Earnings spike and intraday market reaction for AMPX stock

The immediate market response was strong: AMPX stock rose 19.35%, opening at $13.47 and reaching a day high of $15.05 before settling near $13.88. Volume of 19,486,446 shares was about 2.66x the average, signaling heavy trader interest and short-covering alongside longer-term buyers. Market commentary tracked the Q4 release and the FY2026 guide, with live coverage on news outlets including MarketBeat and intraday price boards such as Investing.com.

Q4/FY2025 results and FY2026 guidance

Amprius reported Q4/FY2025 results that the market interpreted as a beat and issued FY2026 guidance that exceeded consensus. The company’s reported EPS is -$0.27 trailing twelve months, but management highlighted revenue ramp drivers for aerospace, defense, and EV pilots. The earnings announcement time was on 05 Mar 2026 (08:30 ET). Analysts noted that guidance strength, not profitability, was the primary catalyst for today’s rally.

Valuation, cash and key financial ratios for AMPX stock

Valuation remains elevated relative to current fundamentals: market cap is $1,637,572,167 and the trailing PE reads -46.48 due to negative earnings. Price-to-sales is about 28.10, price-to-book is 15.44, and cash per share is $0.58. Amprius shows a healthy current ratio of 6.65 and debt-to-equity of 0.37, but operating cash flow per share is -$0.27. These figures underline growth expectations priced into AMPX stock despite ongoing operating losses.

Technical setup and trading indicators

Technically, AMPX shows momentum but stretched readings: RSI is 58.81, CCI is 178.39 (overbought), and MACD histogram is positive at 0.16, signaling upward momentum. Daily range is $13.25 to $15.05 and ATR is $1.13, implying larger swings ahead. On-balance volume sits at 61,506,126, matching the surge in intraday flow and suggesting conviction behind today’s move.

Meyka AI rates AMPX with a score out of 100 and issues a forecast

Meyka AI rates AMPX with a score out of 100: 69.90 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month price of $17.71 versus the current $13.88, implying 27.60% upside; the three‑year model projects $33.84. Forecasts are model-based projections and not guarantees. These model outputs are presented by Meyka AI, an AI-powered market analysis platform, to help frame risk and opportunity.

Analyst consensus, sector context and key risks for AMPX stock

Sell-side coverage tilts bullish on growth: consensus counts 10 buys and no holds or sells, yielding a consensus score of 4.00. Amprius competes in the Industrials sector, Electrical Equipment & Parts industry, where defense UAS demand and EV pilot programs can boost addressable market. Key risks include continued negative operating cash flow, elevated valuation multiples, and execution risk scaling manufacturing. Watch quarterly cadence and contract wins for evidence the guidance is achievable.

Final Thoughts

Today’s intraday move in AMPX stock reflects a classic growth‑story reaction to earnings and guidance that beat expectations. The rally to $13.88 on 05 Mar 2026 was fueled by a spike in volume and stronger FY2026 guidance, shifting the trade from speculative short squeezes to conviction buying. From a fundamentals lens, Amprius still carries negative EPS (-$0.27) and stretched valuation metrics—price/sales 28.10 and price/book 15.44—which demand execution on production scale and contract conversion. Meyka AI’s forecast model projects a one‑year target of $17.71, implying 27.60% upside versus today’s price; longer‑term scenarios show more upside if revenue scales as modeled. Investors should weigh the growth opportunity from silicon‑anode leadership against persistent cash‑flow and execution risks. Monitoring quarterly revenue ramps, margin trends, and defense contract progress will be decisive for AMPX stock’s next leg higher. See our intraday tracker and detailed metrics on the Meyka AMPX page for updates: Meyka AMPX page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.